Country Websites

The Novalung® System
for ECMO*

Designed to Provide Safety,
Simplicity, and Portability

Why the Novalung System?

The Novalung System's single integrated platform focuses on improving the delivery, duration, and impact of life-saving care. This technology is designed to oxygenate blood, remove CO2, and is a good option for ECMO-assisted cardiopulmonary resuscitation (ECPR), patients who need assistance weaning from cardiopulmonary bypass (CPB), and extracorporeal carbon dioxide removal (ECCO2R).

Safety

Designed to minimize emergent circuit changes

Simplicity

Intuitive user-interface designed to simplify workflow and save time

Portability

Designed to ease transport throughout the hospital

The Novalung System for ECMO

Oxygenator

Click here to see our Oxygenator in action.

DP3 Pump Head

Click here to see our DP3 Pump Head in action.

Contact Us for More Information

*ECMO, extracorporeal membrane oxygenation.

References

  1. Data on File.
  2. Novalung Console. Instructions for Use. Fresenius Medical Care North America; 2019. Item no. 38350277. Version: US_003_2019_08.
  3. Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S. Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician. Circulation. 2019;140(24):2019-2037. doi:10.1161/CIRCULATIONAHA.119.034512
  4. Fleck T, Benk C, Klemm R, et al. First serial in vivo results of mechanical circulatory support in children with a new diagonal pump. Eur J Cardiothorac Surg. 2013;44(5):828-835. doi:10.1093/ejcts/ezt427
  5. X-Lung Kit. Instructions for Use. Fresenius Medical Care North America; 2019. Item no: 8200733. Version: US_003_2019_08.


INDICATIONS FOR USE

The Novalung System is indicated for long-term (>6 hours) respiratory/cardiopulmonary support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the patient's blood in adults with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. These may include:

  • Failure to wean from cardiopulmonary bypass following cardiac surgery in adult patients
  • ECMO-assisted cardiopulmonary resuscitation in adults


Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. The Indications for Use for this device can be found at https://fmcna.com/products/indications-safety-and-warnings.

© 2024 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Novalung, X-Lung and x.ellence are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. D/N US-Novalung-000003 Rev A 04/2024

Oxygenator Specifications5

DP3 Pump Head Specifications5

Novalung® Console and Power Supply Specifications2

Integrated Pressure Sensor Specifications5